MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein

Related Experiment Video

Updated: May 21, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Xiaomin Zhao1, Ramkumar Mohan, Sabire Özcan

  • 1College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi 712100, China.

The Journal of Biological Chemistry
|June 27, 2012
PubMed

Insights

MicroRNA-30d (miR-30d) boosts insulin production and protects pancreatic beta cells from inflammatory damage by targeting MAP4K4. Lower miR-30d levels in diabetic mice suggest its therapeutic potential for diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators in various diseases, including diabetes.
  • miRNAs influence critical pancreatic beta-cell functions such as insulin secretion and proliferation.
  • Previous research identified microRNA-30d (miR-30d) as a glucose-responsive miRNA that enhances insulin gene expression.

Purpose of the Study:

  • To investigate the role of miR-30d in regulating insulin production and protecting pancreatic beta cells.
  • To identify the molecular targets and mechanisms through which miR-30d exerts its effects.
  • To explore the potential of miR-30d as a therapeutic target for diabetes.

Main Methods:

  • Overexpression of miR-30d in pancreatic beta cells.
  • Analysis of insulin production, MafA, and IRS2 expression.
  • Identification of MAP4K4 as a direct miR-30d target using luciferase assays.
  • Assessment of beta-cell protection against TNF-α-induced suppression.
  • Examination of miR-30d and MAP4K4 levels in islets from diabetic db/db mice.

Main Results:

  • Overexpression of miR-30d increased insulin production and MafA expression in beta cells.
  • miR-30d prevented TNF-α-induced reduction of MafA and IRS2.
  • MAP4K4 was identified as a direct target of miR-30d, and its suppression by miR-30d protected beta cells from TNF-α.
  • Reduced miR-30d and elevated MAP4K4 were observed in islets of diabetic db/db mice.

Conclusions:

  • miR-30d plays a crucial role in enhancing insulin transcription and protecting beta cells from inflammatory damage.
  • The protective effects of miR-30d involve the downregulation of MAP4K4.
  • Dysregulation of miR-30d and MAP4K4 is implicated in diabetes pathogenesis.
  • miR-30d represents a promising pharmacological target for diabetes intervention.

More Related Videos

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...